The conference consists of talks given in Oxford, and online e-Presentations which replace conventional posters.
1. Oxford-based, live-streamed talks
The focus of Oxford-based talks will be on clinical use, including practice and policy perspectives:
- Clinical trials - all phases
- Large cohorts
- Long-term data
- Experimental medicine in patients
- Psychotherapy techniques
- Summaries of mechanisms and preclinical science
- Health economics
- Risk mitigation
- Relapse prevention - psychological or pharmacological
- Prophylactic 'vaccination' against depression
- Novel compounds
- Barriers to development
All talks being delivered in Oxford will be live-streamed, recorded and made available to all registered delegates until 5th October 2020.
We are replacing conventional posters with online e-Presentations. These can be about any of the above topics. Submission of preclinical studies are also encouraged.
- Cellular mechanisms
- Animal studies
- Healthy volunteer studies
- Smaller cohort studies and reports of clinic experience
- Case studies
How will the online e-Presentations work?
Authors can create presentations in any format: a conventional poster pdf, or a slide deck of up to 10 slides, or a video presentation of up to 7 minutes. These can be viewed by all registered delegates in the week before the conference from 6pm BST on 27th March, until six months after.
Authors of e-Presentations may either be in-person delegates (ox-delegates) or may be online e-delegates. Having a presentation accepted as an e-Presentation does not guarantee a place as an ox-delegate, but will be taken into consideration.
Each e-presentation will be accompanied by up to three online Webmeetings, each lasting 20 minutes in the week before the main talks - from 27th March to 5th April. In these Webmeetings, the author will present their data in no more than 5 minutes, followed by 15 minutes discussion. Webmeetings will be scheduled depending on the timezones of e-delegates and authors. Any registered delegate may join any Webmeeting to discuss the presentation with the author and others. Where authors are happy to do so, a recording of the Webmeeting will be lodged on the e-Presentation system and will be available to registered delegates until 5th October 2020.
***Please note the draft programme will be updated frequently. ***
Speaker confirmations will be updated throughout December 2019. Current confirmations include:
Elias Dakwar, Columbia, US - Alcohol and drug use disorders
Paul Glue, Otago, NZ - Oral ketamine in anxiety disorders
Sunjeev Kamboj, UCL, UK - Craving in heavy drinkers
Steve Levine, Actify, US - Switching between ketamine and esketamine
Celia Morgan, Exeter, UK - Alcohol relapse prevention
Gerald Sanacora, Yale, US - Translational studies
Robert Schoevers, Groningen, NL - Oral esketamine
Carlos Zarate, NIMH, US - Translational studies